Skip Navigation LinksHome > Editorial Board

Editorial Board

Editors
Johannes Vieweg
University of Florida
Florida, USA
Shahrokh F Shariat
Medical University of Vienna
Vienna, Austria

Editorial Board
R Ackermann
Heinrich Heine University,
Dusslrdorf, Germany

DM Albala
Duke University Medical Center,
Durham, USA

L Boccon-Gibod
Hôpital d’Enfants Armand-Trousseau,
Paris, France

CR Chapple
University of Sheffield,
UK

L Coetzee
Pretoria Urology Hospital,
South Africa

FMJ Debruyne
University Medical Center Nijmegen,
The Netherlands

JB de Kernion
University of California,
Los Angeles, USA

R de Vere White
University of California,
Los Angeles, USA

J Fitzpatrick
University College Dublin,
Ireland

JC Gingell
Bristol Urological Institute,
UK

ET Gonzales Jr
Baylor College of Medicine,
Houston, USA

WF Hendry
Royal Marsden Hospital,
London, UK

MS Litwin
UCLA School of Medicine,
USA

S Müller
University of Bonn,
Germany

AR Mundy
Guys Hospital,
London, UK

AJ Schaeffer
Northwestern University Medical Center,
Chicago, USA

J Schalken
University Hospital Nijmegen,
The Netherlands

CC Schulman
Unversity Clinics,
Brussels, Belgium

UE Studer
University Hospital Berne,
Switzerland

JW Thüroff
Johannes Gutenberg University,
Mainz, Germany

GD Webster
Duke University Medical Center
Durham, USA

MP Wirth
Universitätsklinikum Carl Gustav Carus,
Dresden, Germany

Sections

January

Male lower urinary tract symptoms
Edited by Oliver Reich,
Klinikum Munich-Harlaching,
Ludwig-Maximilians-University Teaching-Hospital,
Munich, Germany

Genetic testing or biomarkers for the detection of prostate cancer
Edited byDaniel Lin,
University of Washington,
Washington, USA

March
Organ sparing surgery in urology
Edited by Inderbir Gill,
Keck School of Medicine, University of Southern California,
California, USA

Training in endourology
Edited by Mahesh Desai,
Muljibhai Patel Urological Hospital,
Nadiad, India

May
Focal therapy of prostate cancer
Edited by Thomas J. Polascik, Duke Cancer Institute,
North Carolina, USA

Active surveillance for favorable risk prostate cancer
Edited by H. Ballentine Carter, John Hopkins School of Medicine, br>Maryland, USA


July
Advances in Female Urology

Edited by Christopher Chapple,Sheffield Teaching Hospitals NHS Foundation Trust/University of Sheffield, Sheffield, UK

Reconstructive urology
Edited by Margit Fisch,
University of Hamburg, Hamburg, Germany

September
The future of kidney cancer: quo vadis
Edited by Vitaly Margulis, UT Southwestern Medical Center, Texas, USA
and Manuela Schmidinger, Medical University of Vienna, Vienna, Austria

Personalized medicine in the management of invasive Bladder cancer
Edited by Maximilian Burger, Caritas-St. Josef Medical Centre, University of Regensburg, Regensburg, Germany
and Andrea B. Apolo, National Cancer Institute, Maryland, USA

November
Imaging in prostate cancer: implications for the urologist
Edited by Mark Emberton,
University College London, London, UK

Urinary diversion 2015: Controversies and new technologies
Edited by Sia Daneshmand,
University of Southern California, California, USA